β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial

1. Villanueva, C.
2. Albillos, A.
3. Genescà, J.
4. Garcia-Pagan, J.C.
5. Calleja, J.L.
6. Aracil, C.
7. Bañares, R.
8. Morillas, R.M.
9. Poca, M.
10. Peñas, B.
11. Augustin, S.
12. Abraldes, J.G.
13. Alvarado, E.
14. Torres, F.
15. Bosch, J.